You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
5 August 2019
RB has announced a strategic investment and partnership deal with Your.MD, the digital technology company with a free service that uses artificial intelligence to provide "Trusted Health Information".
5 August 2019
RB said it had "focused and detailed action plans in place" to accelerate growth at its Health division, as sales fell by 1% on a like-for-like basis in the second quarter of 2019.
19 July 2019
Probi and Karo Pharma have released financial results, Venture Life is pushing on with international expansion, and RB has agreed to pay up to USD1.4 billion to settle a US investigation.
13 June 2019
RB has appointed PepsiCo's Laxman Narasimhan as its new chief executive officer. He will join the company on 16 July 2019 as chief executive officer designate, and will replace Rakesh Kapoor on 1 September 2019.
4 June 2019
France has reverse-switched lozenges containing flurbiprofen from non-prescription to prescription status.
6 May 2019
Worldwide OTC sales at RB dropped by 9% on a like-for-like basis to GBP470 million (USD603 million) in the first quarter of 2019. The company blamed an "unusually weak cold and flu season across the US and several European markets" plus "associated retailer destocking".
26 February 2019
RB is set to launch a dietary supplement for "brain performance" in the US in April 2019. The company said Neuriva would be the "first brand in brain health to offer a holistic ecosystem that supports brain performance".
25 February 2019
RB's Health division reported worldwide sales up by 4% on a like-for-like basis to GBP2.07 billion (USD2.74 billion) in the fourth quarter of 2018. The company said e-commerce now generated around 9% of sales by the division.
22 January 2019
GlaxoSmithKline (GSK), Galenica, Almirall and the US Council for Responsible Nutrition (CRN) have all recently announced people changes.
16 January 2019
Rakesh Kapoor intends to retire as chief executive officer of RB by the end of 2019, after more than eight years in the post and 32 years at the company.